Now showing items 1-3 of 3

    • Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness 

      Rubio-Rivas, Manuel; Ronda, Mar; Padullés, Ariadna; Mitjavila, Francesca; Riera-Mestre, Antoni; García-Forero, Carlos; Iriarte, Adriana; Mora-Luján, José María; Padullés, Núria; Gonzalez, Monica; Solanich, Xavier; Gasa, Merce; Suarez-Cuartin, Guillermo; Sabater-Riera, Joan; Perez-Fernandez, Xose L.; Santacana, Eugenia; Leiva, Elisabet; Ariza-Sole, Albert; Dallaglio, Paolo D.; Quero, Maria; Soriano, Antonio; Pasqualetto, Alberto; Koo, Maylin; Esteve-Luque, Virginia; Antolí, Arnau; Moreno-Gónzalez, Rafael; Yun, Sergi; Cerdà, Pau; Llaberia, Mariona; Formiga, Francesc; Fanlo-Maresma, Marta; Montero, Abelardo; Chivite, David; Capdevila, Olga; Bolao, Ferran; Pintó, Xavier; Llop, Josep; Sabate, Antoni; Guardiola, Jordi; Cruzado, Josep M.; Comin-Colet, Josep; Santos, Salud; Jodar, Ramon; Corbella Virós, Xavier (Elsevier, 2020-12)
      Objectives: To assess the characteristics and risk factors for mortality in patients with severe coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in combination with ...
    • Methylprednisolone pulses plus tacrolimus in addition to standard of care vs. standard of care alone in patients with severe COVID-19. A randomized controlled trial 

      Solanich, Xavier; Antolí, Arnau; Rocamora-Blanch, Gemma; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Riera-Mestre, Antoni; Bas, Jordi; Vicens-Zygmunt, Vanesa; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Mensa-Vilaró, Anna; Arregui, Laura; Tebé, Cristian; Videla, Sebastià; Hereu, Pilar; Corbella Virós, Xavier (Frontiers in Medicine, 2021)
      Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, ...
    • Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol 

      Solanich, Xavier; Antolí, Arnau; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Molina, M.; Sabater-Riera, Joan; Bas, Jordi; Mensa-Vilaró, Anna; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Arregui, Laura; Tebé, Cristian; Hereu, Pilar; Videla, S.; Corbella Virós, Xavier (Contemporary Clinical Trials Communications, 2021-03)
      Introduction: Some COVID-19 patients evolve to severe lung injury and systemic hyperinflammatory syndrome triggered by both the coronavirus infection and the subsequent host-immune response. Accordingly, ...